Skip to content

D&A at other companies

EverQuote logo
EverQuoteEVER
$785K-35.7%
MediaAlpha logo
MediaAlphaMAX
$74K+19.4%
Clover Health Investments logo
Clover Health InvestmentsCLOV
$515K+10.5%
Alignment Healthcare logo
Alignment HealthcareALHC
$7.86M+3.1%
LendingTree logo
LendingTreeTREE
$4.19M-2.6%
Agilon Health logo
Agilon HealthAGL
$6.79M-1.3%

Other financials

Income statement

See full
Revenue$430.9M+5.6%
Gross profit$259.6M+5.6%
Operating income$35.9M+62.9%
Net income$40.2M+54.5%
EPS (diluted)$0.11+267%

Balance sheet

See full
Cash & equivalents$35.2M-59.2%
Total debt$404.8M-4.5%
Total equity$384.7M+9.9%
Total assets$1.3B+3.0%

Cash flow

See full
Operating cash flow$56.8M-20.2%
CapEx$947.0K-0.2%
Free cash flow$55.8M-20.4%

Valuation

See full
Market cap$139.42M-65.1%
Enterprise value$509.04M-34.8%
P/E1.5×-6.9×
P/S0.1×-0.2×

Profitability

See full
Gross margin54.2%-7.6pp
Operating margin5.4%
Net margin5.6%+5.3pp
FCF margin-0.4%-3.3pp

Returns & leverage

See full
Return on equity25%+23.9pp
Debt / equity1.1×-0.2×
Current ratio1.6×-0.3×

Where this comes from

Reported directly by SelectQuote in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAmortizationAndAccretionNet.

The official record: SelectQuote’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about SelectQuote's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SelectQuote's D&A?
SelectQuote (SLQT) reported D&A of $4.39M in Q1 2026.
How has SelectQuote's D&A changed year-over-year?
SelectQuote's D&A decreased by 11.0% year-over-year, from $4.93M to $4.39M.
What is the long-term trend for SelectQuote's D&A?
Over 3 years (2022 to 2025), SelectQuote's D&A has grown at a -6.1% compound annual growth rate (CAGR), from $24.72M to $20.46M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.